Rockwell Medical (RMTI) Net Cash Flow Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | -13.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.57% |
| Mar 31, 2026 | 73.43% |
| Dec 31, 2025 | -188.42% |
| Sep 30, 2025 | 127.94% |
| Jun 30, 2025 | -78.29% |
| Mar 31, 2025 | -82.44% |
| Dec 31, 2024 | 171.87% |
| Sep 30, 2024 | 139.70% |
| Jun 30, 2024 | 370.11% |
| Mar 31, 2024 | -394.47% |
| Dec 31, 2023 | 142.49% |
| Sep 30, 2023 | 93.26% |
| Jun 30, 2023 | -109.27% |
| Mar 31, 2023 | 123.63% |
| Dec 31, 2022 | 71.53% |
| Sep 30, 2022 | -98.04% |
| Jun 30, 2022 | 732.94% |
| Mar 31, 2022 | 74.13% |
| Dec 31, 2021 | -27.44% |
| Sep 30, 2021 | -130.04% |